back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-09-28 17:40 Tx date 2022-09-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+43,750 vol |
80,148 | |
| Filed 2022-09-28 17:39 Tx date 2022-09-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+21,875 vol |
91,485 | |
| Filed 2022-03-09 11:32 Tx date 2022-01-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+9,995 vol |
69,610 | |
| Filed 2021-10-05 15:53 Tx date 2021-10-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+8,539 vol |
59,615 | |
| Filed 2021-10-05 15:52 Tx date 2021-09-30 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Capital IV, L.P. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$175,290
+54,438 vol $3.22 each |
128,607 | |
| Filed 2021-10-05 15:51 Tx date 2021-09-30 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Capital IV (International) L.P. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$4,710
+1,463 vol $3.22 each |
3,456 | |
| Filed 2021-09-21 16:17 Tx date 2021-09-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+26,318 vol |
36,398 | |
| Filed 2021-09-21 16:16 Tx date 2021-09-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+26,318 vol |
||
| Filed 2021-09-21 09:00 Tx date 2021-09-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+26,318 vol |
||
| Filed 2021-09-21 09:00 Tx date 2021-09-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+26,318 vol |
36,398 | |
| Filed 2021-09-21 08:57 Tx date 2021-09-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+13,159 vol |
51,076 | |
| Filed 2021-07-07 08:29 Tx date 2021-07-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
$25,176
+3,536 vol $7.12 each |
37,917 | |
| Filed 2021-04-27 16:26 Tx date 2021-04-22 |
$EDSA
Edesa Biotech, Inc. |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+20,000 vol |
51,389 | |
| Filed 2021-04-05 10:55 Tx date 2021-04-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+3,195 vol |
34,381 | |
| Filed 2021-02-25 11:51 Tx date 2021-02-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Ventures III (International), L.P. (Indirect Ownership)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$65,018
+9,661 vol $6.73 each |
9,661 | |
| Filed 2021-02-25 11:51 Tx date 2018-10-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Ventures III (International), L.P. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-02-25 11:50 Tx date 2021-02-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Ventures III (International), L.P. (Indirect Ownership)
|
Warrants
15 - Acquisition or disposition under a prospectus
|
+4,830 vol |
4,830 | |
| Filed 2021-02-25 11:49 Tx date 2018-10-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Ventures III (International), L.P. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-02-25 11:49 Tx date 2021-02-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Ventures III, L.P. (Indirect Ownership)
|
Warrants
15 - Acquisition or disposition under a prospectus
|
+145,170 vol |
145,170 | |
| Filed 2021-02-25 11:47 Tx date 2018-10-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Ventures III, L.P. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-02-25 11:47 Tx date 2021-02-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Ventures III, L.P. (Indirect Ownership)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$1,953,981
+290,339 vol $6.73 each |
290,339 | |
| Filed 2021-02-25 11:46 Tx date 2018-10-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Ventures III, L.P. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-12-23 12:09 Tx date 2020-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,080 vol |
10,080 | |
| Filed 2020-12-23 12:08 Tx date 2018-10-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-12-23 12:08 Tx date 2020-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+5,040 vol |
31,186 | |
| Filed 2020-10-16 20:48 Tx date 2020-10-13 |
$EDSA
Edesa Biotech, Inc. |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+20,000 vol |
31,389 | |
| Filed 2020-08-26 15:30 Tx date 2020-08-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+13,924 vol |
26,146 | |
| Filed 2020-08-26 15:29 Tx date 2020-08-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+13,924 vol |
||
| Filed 2020-08-26 11:45 Tx date 2020-08-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+13,924 vol |
26,146 | |
| Filed 2020-08-26 11:45 Tx date 2020-08-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+13,924 vol |
||
| Filed 2020-04-04 21:20 Tx date 2020-03-31 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Capital IV, L.P. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$175,291
+74,169 vol $2.36 each |
74,169 | |
| Filed 2020-04-04 21:19 Tx date 2018-10-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Capital IV, L.P. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-04-04 21:19 Tx date 2020-03-31 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Capital IV (International) L.P. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$4,710
+1,993 vol $2.36 each |
1,993 | |
| Filed 2020-04-04 21:17 Tx date 2018-10-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Capital IV (International) L.P. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-02-17 18:21 Tx date 2020-02-12 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+11,389 vol |
11,389 | |
| Filed 2020-02-17 18:18 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options Stock Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-13 23:01 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II (International), L.P. (Control or Direction)
|
Warrants Class B Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+5,952 vol |
5,952 | |
| Filed 2020-01-13 23:00 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II (International), L.P. (Control or Direction)
|
Warrants Class B Purchase Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-13 22:59 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II, L.P. (Control or Direction)
|
Warrants Class B Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+64,362 vol |
64,362 | |
| Filed 2020-01-13 22:58 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II, L.P. (Control or Direction)
|
Warrants Class B Purchase Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-13 22:57 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II, L.P. (Control or Direction)
|
Warrants Class A Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+96,542 vol |
96,542 | |
| Filed 2020-01-13 22:56 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II, L.P. (Control or Direction)
|
Warrants Class A Purchase Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-13 22:55 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II (International), L.P. (Control or Direction)
|
Warrants Class A Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+8,928 vol |
8,928 | |
| Filed 2020-01-13 22:48 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II (International), L.P. (Control or Direction)
|
Warrants Class A Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+96,542 vol |
||
| Filed 2020-01-13 22:47 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II (International), L.P. (Control or Direction)
|
Warrants Class A Purchase Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-13 22:46 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II (International), L.P. (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$38,089
+11,903 vol $3.20 each |
169,502 | |
| Filed 2020-01-13 22:45 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II, L.P. (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$411,910
+128,722 vol $3.20 each |
1,833,066 | |
| Filed 2019-07-31 14:04 Tx date 2019-07-26 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II (International), L.P. (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+8,600 vol |
157,599 | |
| Filed 2019-07-31 14:04 Tx date 2019-07-26 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II, L.P. (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+93,006 vol |
1,704,344 | |
| Filed 2019-06-20 17:36 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II (International), L.P. (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-744,992 vol |
148,999 | |
| Filed 2019-06-20 17:32 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II, L.P. (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-8,056,689 vol |
1,611,338 | |
| Filed 2019-06-20 17:31 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II (International), L.P. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
893,991 | ||
| Filed 2019-06-20 17:30 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II, L.P. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
9,668,027 | ||
| Filed 2019-03-05 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+12,222 vol |
||
| Filed 2019-03-05 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+12,222 vol |
12,222 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+12,222 vol |
12,222 | |
| Filed 2018-12-21 Tx date 2018-10-16 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-10-22 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Capital IV (International) L.P. (Control or Direction)
|
Convertible Debentures 6% Unsecured
00 - Opening Balance-Initial SEDI Report
|
$157,000 | ||
| Filed 2018-10-22 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Capital IV, L.P. (Control or Direction)
|
Convertible Debentures 6% Unsecured
00 - Opening Balance-Initial SEDI Report
|
$5,843,000 |